Punjab's exports confront tariff realignments & market concentration. While engineering goods lead, the state's share in national exports declines. Can diversification & new FTAs build resilience?
Nivin Pauly's OTT debut 'Pharma' trailer reveals a medical rep exposing dangerous drugs. The series premieres on JioCinema December 19 in 7 languages. Read more.
Commerce Minister Piyush Goyal states November's export recovery negates October's decline, highlighting strong 8.2% Q2 growth and robust forex reserves. Explore India's economic resilience.
India's merchandise exports posted a healthy rise in November, recovering from October's sharp fall. Commerce Minister Piyush Goyal highlights growth amidst global volatility and ongoing FTA talks. Official data due Dec 15.
GTRI warns global trade slowdown may jeopardize India's $451 billion export target. Electronics and labor-intensive sectors face highest risk. Learn how India can navigate these challenges.
India's exports to the US plummeted 28.5% in five months due to high American tariffs. GTRI report reveals significant trade challenges ahead. Read analysis.
India's engineering exports declined by 21% in October 2023, dragged down by reduced shipments to US and ASEAN markets. Key sectors face challenges amid global economic slowdown.
Indian API manufacturers are shifting to high-value contract development, targeting $22-25 billion market by 2035 as global pharma diversifies from China. Read about the growth trajectory.
Speciality chemical makers supplying pharma CDMOs post 7% sales growth, outpacing non-pharma peers. Strong margins and global shifts fuel this resilient sector. Read more.
Sudeep Pharma shares surged 33.78% in market debut, exceeding expectations. Analysts advise partial profit booking while maintaining long-term optimism. Read expert views on buy/sell strategy.
Sudeep Pharma shares surged 23% in stock market debut today, outperforming grey market expectations. The ₹895-crore IPO was subscribed 93.71 times. Read full analysis.
Sudeep Pharma makes its stock market debut today. With a GMP of ₹121, the IPO is set for 20% listing gains after a blockbuster 93.72 times subscription. Get all the live details.
Sudeep Pharma IPO allotment likely on November 26. Learn how to check allotment status via BSE, NSE, registrar. Strong 93.72x subscription signals investor confidence.
India's merchandise exports show strong recovery in November after October decline. Commerce Minister Piyush Goyal reveals positive growth trends and SEZ reforms to boost competitiveness.
India emerges as unexpected mozzarella exporter with 1200% growth, challenging Western dominance. Buffalo milk cheese gains global recognition amid booming pizza demand.
India's seafood exports surge 18% to $2.43 billion as the sector strategically diversifies beyond the US market. Driven by strong demand from China, Vietnam, and Europe, this shift offsets rising American tariffs. Discover how this strategic pivot is resh
Sudeep Pharma's ₹895 crore IPO is fully subscribed. With a GMP of ₹121, investors eye a 20% listing gain. Track all live updates here.
Sudeep Pharma's IPO concludes November 25 after strong第一天 response. Grey market premium hits ₹121, signaling 20% listing gains. Key dates and subscription details revealed.
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
India's IPO market surges with ₹76,000 crore offerings. Excelsoft Technologies fully subscribed, Sudeep Pharma at 50%. Expert analysis on both IPOs and GMP trends revealed.
Sudeep Pharma's ₹895 crore IPO opens with ₹563-593 price band. Grey market shows ₹130 premium. Analysts recommend long-term investment for 2-5 years horizon.
Sudeep Pharma's ₹895 crore IPO opens today. Price band ₹563-593 per share. Learn about company details, investment minimums & global presence. Subscribe now!
Global automakers use India's ICE vehicle strength to counter Chinese EV dominance in emerging markets. Suzuki, Hyundai, Volkswagen ramp up exports from India to Africa, Middle East, and Latin America.
Sudeep Pharma's ₹95 crore IPO opens November 21 with strong grey market premium. Learn price band, dates, financials & investment details for this pharma ingredients maker.
Sudeep Pharma's ₹895 crore IPO opens November 21-25. Price band ₹563-593 per share. Company manufactures pharmaceutical excipients and speciality ingredients.
India's exports to the US surge 14.5% in October, breaking 4-month decline streak. November tariff cuts on $3 billion goods set to boost trade further. Read analysis.
Union Minister Piyush Goyal announces India's export growth strategy with EU trade agreement advancing. Fishery approvals to boost marine exports significantly. Read more.